PMID- 38419188 OWN - NLM STAT- Publisher LR - 20240229 IS - 1460-9568 (Electronic) IS - 0953-816X (Linking) DP - 2024 Feb 28 TI - Diabetes mellitus and Alzheimer's disease: Vacuolar adenosine triphosphatase as a potential link. LID - 10.1111/ejn.16286 [doi] AB - Globally, the incidence of diabetes mellitus (DM) and Alzheimer's disease (AD) is increasing year by year, causing a huge economic and social burden, and their pathogenesis and aetiology have been proven to have a certain correlation. In recent years, more and more studies have shown that vacuolar adenosine triphosphatases (v-ATPases) in eukaryotes, which are biomolecules regulating lysosomal acidification and glycolipid metabolism, play a key role in DM and AD. This article describes the role of v-ATPase in DM and AD, including its role in glycolysis, insulin secretion and insulin resistance (IR), as well as its relationship with lysosomal acidification, autophagy and beta-amyloid (Abeta). In DM, v-ATPase is involved in the regulation of glucose metabolism and IR. v-ATPase is closely related to glycolysis. On the one hand, v-ATPase affects the rate of glycolysis by affecting the secretion of insulin and changing the activities of key glycolytic enzymes hexokinase (HK) and phosphofructokinase 1 (PFK-1). On the other hand, glucose is the main regulator of this enzyme, and the assembly and activity of v-ATPase depend on glucose, and glucose depletion will lead to its decomposition and inactivation. In addition, v-ATPase can also regulate free fatty acids, thereby improving IR. In AD, v-ATPase can not only improve the abnormal brain energy metabolism by affecting lysosomal acidification and autophagy but also change the deposition of Abeta by affecting the production and degradation of Abeta. Therefore, v-ATPase may be the bridge between DM and AD. CI - (c) 2024 Federation of European Neuroscience Societies and John Wiley & Sons Ltd. FAU - Guo, Bin AU - Guo B AUID- ORCID: 0000-0001-5199-5456 AD - Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China. FAU - Li, Qi-Ye AU - Li QY AD - Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China. FAU - Liu, Xue-Jia AU - Liu XJ AD - Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China. FAU - Luo, Guo-Hui AU - Luo GH AD - Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China. FAU - Wu, Ya-Juan AU - Wu YJ AD - Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China. FAU - Nie, Jing AU - Nie J AD - Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China. LA - eng GR - 82260842/National Natural Science Foundation of China/ GR - [2020]1Z075/Science and Technology Project Fund of Guizhou Province/ GR - [2020]252/Key Laboratory of Basic Pharmacology of the Ministry of Education and Joint International Research Laboratory of Ethnomedicine of the Ministry of Education Funds/ PT - Journal Article PT - Review DEP - 20240228 PL - France TA - Eur J Neurosci JT - The European journal of neuroscience JID - 8918110 SB - IM OTO - NOTNLM OT - Alzheimer's disease OT - diabetes mellitus OT - insulin resistance OT - vacuolar adenosine triphosphatases OT - beta-amyloid EDAT- 2024/02/29 06:43 MHDA- 2024/02/29 06:43 CRDT- 2024/02/29 00:23 PHST- 2024/02/01 00:00 [revised] PHST- 2023/12/01 00:00 [received] PHST- 2024/02/02 00:00 [accepted] PHST- 2024/02/29 06:43 [medline] PHST- 2024/02/29 06:43 [pubmed] PHST- 2024/02/29 00:23 [entrez] AID - 10.1111/ejn.16286 [doi] PST - aheadofprint SO - Eur J Neurosci. 2024 Feb 28. doi: 10.1111/ejn.16286.